Inicio・Lista de Acciones・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Cerrado

SectorSanidad

35.28 -0.95

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

35.04

Máximo

35.67

Métricas clave
By Trading Economics
Ingresos	10M 32M
Ventas	-28M 215M
P/B Media del Sector	13.618 62.58
BPA	0.79
Margen de beneficios	15.084
Empleados	293
EBITDA	-2.8M 49M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 Meses	+13.72% upside

Dividendos
By Acuity
Próximas Ganancias	4 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	54M 1.9B
Apertura anterior	36.23
Cierre anterior	35.28

Noticias sobre sentimiento de mercado

By Acuity

50%

163 / 340 Clasificación en Healthcare

Harmony Biosciences Holdings Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 jul 2026, 17:06 UTC

Shares of Harmony Biosciences Holdings Inc. are lower today, continuing a decline since Thursday's close, despite earlier reaching a session high.

22 jul 2026, 20:01 UTC

News

Harmony Biosciences Holdings Inc is trading lower despite preliminary Q2 2026 results showing record net product revenue of approximately $261 million, a 30% year-over-year increase.

21 jul 2026, 21:01 UTC

Harmony Biosciences Holdings Inc. shares are lower in after-market trading, diverging from a broader market rebound despite no specific news driving the decline.

Comparación entre iguales

Cambio de precio

Harmony Biosciences Holdings Inc previsión

Precio Objetivo

By TipRanks

13.72% repunte

Estimación a 12 Meses

Media 40.71 USD 13.72%

Máximo 55 USD

Mínimo 29 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

Comprar

Mantener

Vender

De acuerdo con 7 analistas que ofrecen calificaciones bursátiles a para Harmony Biosciences Holdings Inc Dist en los últimos 3 meses.

Sentimiento

By Acuity

163 / 340 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.